CN1539460A - 一种补肾壮阳延龄长春中药制剂及制备方法 - Google Patents
一种补肾壮阳延龄长春中药制剂及制备方法 Download PDFInfo
- Publication number
- CN1539460A CN1539460A CNA2003101032162A CN200310103216A CN1539460A CN 1539460 A CN1539460 A CN 1539460A CN A2003101032162 A CNA2003101032162 A CN A2003101032162A CN 200310103216 A CN200310103216 A CN 200310103216A CN 1539460 A CN1539460 A CN 1539460A
- Authority
- CN
- China
- Prior art keywords
- preparation
- age
- chinese medicine
- testis
- ointment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000003734 kidney Anatomy 0.000 title claims abstract description 18
- 238000000034 method Methods 0.000 title claims description 79
- 238000002360 preparation method Methods 0.000 title claims description 51
- 239000002398 materia medica Substances 0.000 title 1
- 239000003814 drug Substances 0.000 claims abstract description 37
- 210000003899 penis Anatomy 0.000 claims abstract description 29
- 241000208340 Araliaceae Species 0.000 claims abstract description 17
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 17
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 17
- 235000008434 ginseng Nutrition 0.000 claims abstract description 17
- 239000002775 capsule Substances 0.000 claims description 42
- 210000001550 testis Anatomy 0.000 claims description 40
- 239000002674 ointment Substances 0.000 claims description 30
- 239000000843 powder Substances 0.000 claims description 30
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 21
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 18
- 238000001035 drying Methods 0.000 claims description 18
- 239000007788 liquid Substances 0.000 claims description 18
- 230000008093 supporting effect Effects 0.000 claims description 16
- 239000008187 granular material Substances 0.000 claims description 15
- 230000008569 process Effects 0.000 claims description 14
- 241001550206 Colla Species 0.000 claims description 13
- 241000238040 Panulirus Species 0.000 claims description 13
- 241000927735 Penaeus Species 0.000 claims description 13
- 210000001320 hippocampus Anatomy 0.000 claims description 13
- 239000000706 filtrate Substances 0.000 claims description 12
- 238000010438 heat treatment Methods 0.000 claims description 12
- 239000002671 adjuvant Substances 0.000 claims description 9
- 239000012153 distilled water Substances 0.000 claims description 9
- 239000006187 pill Substances 0.000 claims description 9
- 235000020357 syrup Nutrition 0.000 claims description 9
- 239000006188 syrup Substances 0.000 claims description 9
- 229920001353 Dextrin Polymers 0.000 claims description 6
- 239000004375 Dextrin Substances 0.000 claims description 6
- 229920002472 Starch Polymers 0.000 claims description 6
- 235000008504 concentrate Nutrition 0.000 claims description 6
- 239000012141 concentrate Substances 0.000 claims description 6
- 235000019425 dextrin Nutrition 0.000 claims description 6
- 238000000605 extraction Methods 0.000 claims description 6
- 239000012467 final product Substances 0.000 claims description 6
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- 238000010992 reflux Methods 0.000 claims description 6
- 235000020374 simple syrup Nutrition 0.000 claims description 6
- 239000008107 starch Substances 0.000 claims description 6
- 235000019698 starch Nutrition 0.000 claims description 6
- 239000002994 raw material Substances 0.000 claims description 5
- -1 drying Substances 0.000 claims description 4
- 238000005516 engineering process Methods 0.000 claims description 4
- 229930006000 Sucrose Natural products 0.000 claims description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 3
- 230000002421 anti-septic effect Effects 0.000 claims description 3
- 235000019359 magnesium stearate Nutrition 0.000 claims description 3
- 239000005720 sucrose Substances 0.000 claims description 3
- 239000003826 tablet Substances 0.000 claims description 3
- 238000010298 pulverizing process Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 13
- 210000003056 antler Anatomy 0.000 abstract description 4
- 230000036039 immunity Effects 0.000 abstract description 2
- 241000282994 Cervidae Species 0.000 abstract 1
- 240000001341 Reynoutria japonica Species 0.000 abstract 1
- 235000018167 Reynoutria japonica Nutrition 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 238000012360 testing method Methods 0.000 description 18
- 241000700159 Rattus Species 0.000 description 12
- 241000699670 Mus sp. Species 0.000 description 11
- 230000037396 body weight Effects 0.000 description 11
- 230000003203 everyday effect Effects 0.000 description 11
- 241001465754 Metazoa Species 0.000 description 10
- 241000699666 Mus <mouse, genus> Species 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 229940079593 drug Drugs 0.000 description 9
- 201000010099 disease Diseases 0.000 description 7
- 239000008280 blood Substances 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 230000027326 copulation Effects 0.000 description 6
- 239000007924 injection Substances 0.000 description 6
- 238000002347 injection Methods 0.000 description 6
- 231100000682 maximum tolerated dose Toxicity 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 206010016256 fatigue Diseases 0.000 description 5
- 230000009182 swimming Effects 0.000 description 5
- 238000005303 weighing Methods 0.000 description 5
- WQZGKKKJIJFFOK-SVZMEOIVSA-N (+)-Galactose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-SVZMEOIVSA-N 0.000 description 4
- 238000012449 Kunming mouse Methods 0.000 description 4
- 102000019197 Superoxide Dismutase Human genes 0.000 description 4
- 108010012715 Superoxide dismutase Proteins 0.000 description 4
- PDMMFKSKQVNJMI-BLQWBTBKSA-N Testosterone propionate Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](OC(=O)CC)[C@@]1(C)CC2 PDMMFKSKQVNJMI-BLQWBTBKSA-N 0.000 description 4
- 210000004556 brain Anatomy 0.000 description 4
- 238000011534 incubation Methods 0.000 description 4
- 230000002035 prolonged effect Effects 0.000 description 4
- 229960001712 testosterone propionate Drugs 0.000 description 4
- 208000019914 Mental Fatigue Diseases 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 3
- 238000011047 acute toxicity test Methods 0.000 description 3
- 238000010171 animal model Methods 0.000 description 3
- 206010003549 asthenia Diseases 0.000 description 3
- 210000003414 extremity Anatomy 0.000 description 3
- 210000001624 hip Anatomy 0.000 description 3
- 201000001881 impotence Diseases 0.000 description 3
- 210000000629 knee joint Anatomy 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 230000003285 pharmacodynamic effect Effects 0.000 description 3
- 206010036596 premature ejaculation Diseases 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 230000002087 whitening effect Effects 0.000 description 3
- 206010002091 Anaesthesia Diseases 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- QGMRQYFBGABWDR-UHFFFAOYSA-M Pentobarbital sodium Chemical compound [Na+].CCCC(C)C1(CC)C(=O)NC(=O)[N-]C1=O QGMRQYFBGABWDR-UHFFFAOYSA-M 0.000 description 2
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 230000037005 anaesthesia Effects 0.000 description 2
- 230000002146 bilateral effect Effects 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 238000003304 gavage Methods 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 239000007927 intramuscular injection Substances 0.000 description 2
- 238000010255 intramuscular injection Methods 0.000 description 2
- 231100001252 long-term toxicity Toxicity 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 229940049954 penicillin Drugs 0.000 description 2
- 229960002275 pentobarbital sodium Drugs 0.000 description 2
- 230000035479 physiological effects, processes and functions Effects 0.000 description 2
- 230000002980 postoperative effect Effects 0.000 description 2
- 230000036299 sexual function Effects 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- UYIFTLBWAOGQBI-BZDYCCQFSA-N Benzhormovarine Chemical compound C([C@@H]1[C@@H](C2=CC=3)CC[C@]4([C@H]1CC[C@@H]4O)C)CC2=CC=3OC(=O)C1=CC=CC=C1 UYIFTLBWAOGQBI-BZDYCCQFSA-N 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 206010020852 Hypertonia Diseases 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000003044 adaptive effect Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 239000004490 capsule suspension Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000007159 enucleation Effects 0.000 description 1
- 229950002007 estradiol benzoate Drugs 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 229960003387 progesterone Drugs 0.000 description 1
- 239000000186 progesterone Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000000384 rearing effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000012109 statistical procedure Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 238000002562 urinalysis Methods 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2003101032162A CN1272055C (zh) | 2003-10-30 | 2003-10-30 | 一种补肾壮阳延龄长春中药制剂的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2003101032162A CN1272055C (zh) | 2003-10-30 | 2003-10-30 | 一种补肾壮阳延龄长春中药制剂的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1539460A true CN1539460A (zh) | 2004-10-27 |
CN1272055C CN1272055C (zh) | 2006-08-30 |
Family
ID=34333244
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2003101032162A Expired - Fee Related CN1272055C (zh) | 2003-10-30 | 2003-10-30 | 一种补肾壮阳延龄长春中药制剂的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1272055C (zh) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101912487A (zh) * | 2010-08-03 | 2010-12-15 | 彭树林 | 一种治疗神经内分泌紊乱、性功能衰退及皮肤老化的药物 |
CN102274263A (zh) * | 2011-09-08 | 2011-12-14 | 珲春华瑞参业生物工程有限公司 | 一种山参茸鞭胶囊及制备方法 |
CN102614441A (zh) * | 2011-01-26 | 2012-08-01 | 广州万正药业有限公司 | 一种药物组合物及其制备方法 |
CN104940234A (zh) * | 2015-06-01 | 2015-09-30 | 江西省牧蕾农林开发有限公司 | 一种提高免疫力强身健体增强男性性功能的保健品 |
CN106177317A (zh) * | 2016-07-29 | 2016-12-07 | 中国农业科学院特产研究所 | 一种温肾壮阳、强筋健骨的即食鹿茸片及其制备方法 |
CN106421334A (zh) * | 2015-08-21 | 2017-02-22 | 牟之梨 | 一种治疗因房事过度导致阳痿的中药组方 |
CN108294307A (zh) * | 2018-01-17 | 2018-07-20 | 上海茂久中医药科技有限公司 | 一种含有鸡睾丸、鸡冠、淫羊藿的营养品 |
CN109259219A (zh) * | 2018-10-24 | 2019-01-25 | 吉林海王健康生物科技有限公司 | 一种鹿鞭蜜丸及其制备方法 |
-
2003
- 2003-10-30 CN CNB2003101032162A patent/CN1272055C/zh not_active Expired - Fee Related
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101912487A (zh) * | 2010-08-03 | 2010-12-15 | 彭树林 | 一种治疗神经内分泌紊乱、性功能衰退及皮肤老化的药物 |
CN101912487B (zh) * | 2010-08-03 | 2012-11-21 | 彭树林 | 一种治疗神经内分泌紊乱、性功能衰退及皮肤老化的药物 |
CN102614441A (zh) * | 2011-01-26 | 2012-08-01 | 广州万正药业有限公司 | 一种药物组合物及其制备方法 |
CN102614441B (zh) * | 2011-01-26 | 2014-04-30 | 广州万正药业有限公司 | 一种药物组合物及其制备方法 |
CN102274263A (zh) * | 2011-09-08 | 2011-12-14 | 珲春华瑞参业生物工程有限公司 | 一种山参茸鞭胶囊及制备方法 |
CN102274263B (zh) * | 2011-09-08 | 2014-08-06 | 珲春华瑞参业生物工程有限公司 | 一种山参茸鞭胶囊及制备方法 |
CN104940234A (zh) * | 2015-06-01 | 2015-09-30 | 江西省牧蕾农林开发有限公司 | 一种提高免疫力强身健体增强男性性功能的保健品 |
CN106421334A (zh) * | 2015-08-21 | 2017-02-22 | 牟之梨 | 一种治疗因房事过度导致阳痿的中药组方 |
CN106177317A (zh) * | 2016-07-29 | 2016-12-07 | 中国农业科学院特产研究所 | 一种温肾壮阳、强筋健骨的即食鹿茸片及其制备方法 |
CN108294307A (zh) * | 2018-01-17 | 2018-07-20 | 上海茂久中医药科技有限公司 | 一种含有鸡睾丸、鸡冠、淫羊藿的营养品 |
CN109259219A (zh) * | 2018-10-24 | 2019-01-25 | 吉林海王健康生物科技有限公司 | 一种鹿鞭蜜丸及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN1272055C (zh) | 2006-08-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1245187C (zh) | 一种治疗由脏腑病所致眼病的药物 | |
CN1857690A (zh) | 妇科病制剂及新的制备方法 | |
CN1712054A (zh) | 秦川通痹片 | |
CN1108804C (zh) | 一种治疗糖尿病的药物及其制备方法 | |
CN1272055C (zh) | 一种补肾壮阳延龄长春中药制剂的制备方法 | |
CN1742775A (zh) | 一种预防和治疗骨科疾病的药物组合物 | |
CN1840160A (zh) | 抗骨质增生粉 | |
CN1048636C (zh) | 一种根治毒瘾的戒毒中药制剂及其制法 | |
CN112494569B (zh) | 一种提高免疫力的中药组合物及其制备方法和用途 | |
CN1907335A (zh) | 一种用于治疗鼻渊的药物组合物及其制备方法 | |
CN1562116A (zh) | 一种具有壮肾功能的中药制药 | |
CN1250247C (zh) | 一种补肾壮阳鹿阳强肾中药制剂及制备方法 | |
CN101474277B (zh) | 一种治疗风湿病的药物组合物及其制备方法 | |
CN1814163A (zh) | 治疗心、脑血栓性疾病的中药及制备方法 | |
CN103751692B (zh) | 一种海狗鞭特补胶囊及其制备方法 | |
CN1278734C (zh) | 一种用于戒毒的药物组合物及其制备方法 | |
CN1092968C (zh) | 一种治疗寒冷期外周血管病的药物 | |
CN107737259A (zh) | 一种提高男性性功能的中药组方 | |
CN1471954A (zh) | 一种中药戒毒药物 | |
CN111643606B (zh) | 一种用以治疗失眠的凝胶贴膏及其制备方法 | |
CN1785410A (zh) | 一种治疗痛症的中成药颗粒剂的制备方法 | |
CN1242770C (zh) | 一种治疗外感风热咳嗽的药物组合物及其制备方法 | |
CN1857559A (zh) | 治疗阳痿药物及其制备方法 | |
CN101045116A (zh) | 一种治疗胆囊炎的中药药物 | |
CN1261121C (zh) | 一种治疗便秘、口臭、牙龈肿痛的药物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PP01 | Preservation of patent right |
Effective date of registration: 20070618 Pledge (preservation): Preservation |
|
PD01 | Discharge of preservation of patent |
Date of cancellation: 20080618 Pledge (preservation): Preservation registration |
|
ASS | Succession or assignment of patent right |
Owner name: LIAOYUAN YULONGYA PHARMACEUTICAL CO.LTD. Free format text: FORMER OWNER: LIAOYUAN YADONG MEDICINE CO., LTD., JILIN PROVINCE Effective date: 20080926 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20080926 Address after: Jilin city of Liaoyuan province Yiyang Friendship Road No. 5 Patentee after: LIAOYUAN YULONGYADONG PHARMACEUTICAL Co.,Ltd. Address before: No. 33 Youyi Road, Jilin, Liaoyuan Patentee before: Jilin Liaoyuan Yadong Pharmaceutical Co.,Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20060830 |